Using Diagnostic Tools to Stage Breast Cancer
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 9/21/2018 |
| Start Date: | March 2002 |
| End Date: | August 1, 2020 |
Evaluation of Multimodality Breast Imaging: Lesion Staging
This project is aimed at investigating the relative diagnostic and synergy of four state of
the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital
mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to
determining the extent of breast cancer.
the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital
mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to
determining the extent of breast cancer.
Inclusion Criteria:
- Women recently diagnosed with Breast Cancer
- Will be undergoing surgery (after study) at the Hospital of the University of
Pennsylvania
Exclusion Criteria:
- Contraindications to MRI
- previously diagnosed with breast cancer (in the smae breast) within the past 5 years
- Patients with known locally advanced cancer (prior to study entry) being treated with
preoperative adjuvant therapy.
- Pregnant women
We found this trial at
1
site
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
Click here to add this to my saved trials
